Willing and able to travel frequently throughout the North Central territory, including Idaho, Illinois, Indiana, Iowa, Michigan, Montana, Nebraska, North Dakota, South Dakota, Wisconsin, Wyoming, with primary coverage of major metropolitan and academic medical center markets across the region. Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders.